Articolul precedent |
Articolul urmator |
331 1 |
Ultima descărcare din IBN: 2022-04-16 07:44 |
SM ISO690:2012 GONCIARUC, Valeriu, CEBANU, Mariana. Incidence of bradyarrhythmias in patients during acute phase of COVID-19. Literature review. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 187. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | ||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | ||||||
|
||||||
Pag. 187-187 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Bradyarrhythmia, although rarely reported in the COVID-19 profile articles, occupies an important niche in the contrasting polymorphism of clinical manifestations of these diseases, being as well a significant marker in prognosis anticipation. Objective of the study. Analysis of the incidence of bradyarrhythmias, their causes and impact on the management strategies of patients with acute COVID-19, in the light of the clinical synthesis published worldwide. Material and Methods. It have been analyzed 15 articles and reports of a series of cases with similar topics, published between 2020 and 2021 on information platforms (Cambridge University Press, Hinari Access, US National Library of Medicine, CDC). Results. According to studies published in China, Italy and US, it results that approximately 17% of patients hospitalized with SARS-CoV-2 infection showed arrhythmogenic complications, and in the ICU departments - 44%. Reporting a series of cases, which targeted 7 people who have been manifested severe bradyarrhythmia, it was noted that only 3 of the 7 (43%) initially had advanced heart block, while the other 4 developed either sinus arrest or an advanced proximal atrioventricular block later. Despite the management of bradycardia, with temporary or permanent implantation of peacemaker, there was a high mortality rate - 71%. Conclusion. Bradycardia can be correlated with a severe evolution of COVID-19 pathology, which requires early management. Future studies, which would elucidate the relationship between SARS-CoV-2 infection and bradycardia, as well as the impact on prognosis, are still needed. |
||||||
Cuvinte-cheie bradyarrhythmias, COVID-19, marker, prognosis, bradiaritmie, COVID-19, marker, prognostic |
||||||
|